Under construction – not a live service
Sign in
Taking people in IraqNo phase

Studies how delays in reaching hospital affect heart attack outcomes

Observes how delays before and during hospital care affect adults with heart attacks.

Plain-language title generated from the registry record
Registry title: Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes

Key facts

Where
Baghdad, IraqSee the site

Where in Iraq

  • College of Medicine - Al-Nahrain UniversityBaghdad, IraqTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Al-Nahrain University
Trial code
NCT06738498
Record updated
17 September 2026
Original description
The goal of this prospective observational study is to investigate the impact of pre-hospital and hospital delays on the outcomes of myocardial infarction (MI) patients admitted to Al-Kadhimiya Teaching Hospital, Baghdad.Read full original descriptionShow less

The Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes: A Prospective Study

The goal of this prospective observational study is to investigate the impact of pre-hospital and hospital delays on the outcomes of myocardial infarction (MI) patients admitted to Al-Kadhimiya Teaching Hospital, Baghdad.

The main questions it aims to answer are:

How do pre-hospital delays (e.g., patient transport and first medical contact) affect clinical outcomes such as mortality, complication rates, and recovery time in MI patients? What is the influence of hospital-related delays (e.g., time to intervention or reperfusion therapy) on the prognosis of MI patients?

Participants will:

Be monitored for the time elapsed from symptom onset to first medical contact and subsequent time intervals during hospital care.

Have their clinical outcomes, including in-hospital mortality, length of stay, and post-intervention complications, recorded and analyzed.

Inclusion: Patients who provide informed consent (or a legal representative provides consent if the patient is unable to do so); Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI); Patients admitted to Al-Kadhimiya Teaching Hospital within 12 hours of symptom onset.

Exclusion: Patients with non-acute myocardial infarction (e.g., stable angina, prior MI); Patients who are transferred to another facility before reperfusion therapy is initiated; Patients with severe comorbidities (e.g., advanced cancer, end-stage renal disease) that may complicate outcome assessments or interfere with treatment protocols; Pregnant women or breastfeeding women.

ClinicalTrials.gov NCT06738498